Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Blood Advances|April 29, 2020
Impact of exercise on the immune system and outcomes in hematologic malignanciesAndrea Sitlinger, Danielle M Brander, David B BartlettScientific Reports|December 1, 2021
A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemiaGrace MacDonald, Andrea Sitlinger, Michael A Deal, et al.Journal of Geriatric Oncology|September 12, 2022
Effects of high-intensity interval training on health-related quality of life in chronic lymphocytic leukemia: A pilot studyAshley L Artese, Andrea Sitlinger, Grace MacDonald, et al.Hematology. American Society of Hematology. Education Program|December 5, 2025
Updates in the management of newly diagnosed chronic lymphocytic leukemiaKristen McClellan, Andrea SitlingerHematology. American Society of Hematology. Education Program|December 4, 2020
Managing toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitorsAshley Hanlon, Danielle M BranderSurgical Oncology Clinics of North America|September 15, 2018
Health-Related Quality of Life: The Impact on Morbidity and MortalityAndrea Sitlinger, Syed Yousuf ZafarPatient Preference and Adherence|April 27, 2012
Update on treatment of follicular non-Hodgkin's lymphoma: focus on potential of bortezomibDanielle M Brander, Anne W BeavenCells|June 2, 2021
Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL)Andrea Sitlinger, Michael A Deal, Erwin Garcia, et al.Cancer Biology & Therapy|March 28, 2018
Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapiesAnthony R Mato, Jennifer C Samp, Geneviève Gauthier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity ModelMax J Gordon, Andy Kaempf, Andrea Sitlinger, et al.Pageof 6